Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

It takes about a decade for a drug ... design drugs, DiffSMol takes only one second to generate a single molecule, said Ziqi ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

Cornell researchers are demonstrating how artificial intelligence—particularly deep learning and generative modeling—can ...

In January, we announced plans to expand the reach of our flagship assay, ChemoFx®, into Europe and to broaden its ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised ...

The $2M Millennium M2000 Supercomputer from Cadence and NVIDIA reshapes chip, drug, and AI design with Blackwell-powered ...

Delivers up to 80X higher performance and 20X lower power; optimized for a broad range of workloads across EDA, system design ...

While Quantum computing has been reported to be five years away for many years now, companies are preparing for it by setting ...

This synergy enables AI-driven breakthroughs, making simulations faster, more scalable, and more energy-efficient across ...

The Millennium M2000 Supercomputer is available both in the cloud and as an on-premises appliance. Multiple customers have provided endorsements, including Ascendance, Boom Supersonic, MediaTek, ...